Related Experiment Video

Updated: Jun 13, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

[Arteriosclerosis obliterans (ASO)]

Megumi Koshikawa1, Uichi Ikeda

  • 1Department of Cardiovascular Medicine, Shinshu University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 8, 2010
PubMed

Insights

Arteriosclerosis Obliterans (ASO) treatment aims to reduce cardiovascular events and prevent limb loss by managing risk factors. Key strategies include lifestyle changes, medication, and surgical interventions for improved patient outcomes.

Area of Science:

  • Vascular Medicine
  • Cardiovascular Disease
  • Peripheral Artery Disease

Context:

  • Arteriosclerosis Obliterans (ASO) significantly impacts patient quality of life and physical function.
  • ASO patients face elevated risks of myocardial infarction and stroke.
  • Limb amputation is a severe complication of untreated ASO.

Purpose:

  • To outline comprehensive treatment goals for Arteriosclerosis Obliterans.
  • To emphasize aggressive management of atherosclerotic risk factors.
  • To highlight strategies for symptom improvement and prevention of severe outcomes.

Summary:

  • ASO treatment focuses on reducing future cardiovascular events and claudication symptoms.
  • Management involves risk factor modification, smoking cessation, exercise, and pharmacologic therapy.
  • Interventional options include angioplasty, stenting, bypass surgery, and therapeutic angiogenesis.

Impact:

  • Effective ASO management can prevent limb amputation and reduce cardiovascular mortality.
  • Improved treatment strategies enhance patient quality of life and physical function.
  • Integrated care addressing both peripheral and systemic atherosclerosis is crucial.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...